Allosteric Inhibitors of Hepatitis C Polymerase: Discovery of Potent and Orally Bioavailable Carbon-Linked Dihydropyrones
- 21 July 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (17) , 3969-3972
- https://doi.org/10.1021/jm0704447
Abstract
The discovery and optimization of a novel class of carbon-linked dihydropyrones as allosteric HCV NS5B polymerase inhibitors are presented. Replacement of the sulfur linker atom with carbon reduced compound acidity and greatly increased cell permeation. Further structure−activity relationship (SAR) studies led to the identification of compounds, exemplified by 23 and 24, with significantly improved antiviral activities in the cell-based replicon assay and favorable pharmacokinetic profiles.Keywords
This publication has 8 references indexed in Scilit:
- Recent development of therapeutics for chronic HCV infectionAntiviral Research, 2006
- Development of a Synthetic Process towards a Hepatitis C Polymerase InhibitorOrganic Process Research & Development, 2006
- 731 Interim results of a multiple ascending dose study of R1626, a novel nucleoside analog targeting hcv polymerase in chronic HCV patientsJournal of Hepatology, 2006
- Antiviral therapy for chronic hepatitis C: past, present, and futureThe Esophagus, 2006
- Control of Hepatitis C: A Medicinal Chemistry PerspectiveJournal of Medicinal Chemistry, 2004
- Hepatitis CJournal of Clinical Gastroenterology, 2000
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999
- Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide ClassJournal of Medicinal Chemistry, 1998